Are you ready to unlock the future of health and longevity? The Wharton Club of Northern California invites you to an exclusive event that will leave you on the cutting edge of healthcare innovation. The Human Longevity SF Center, a pioneer company focusing on longevity to improve Healthcare with Precision Medicine and AI-Driven Analytics. Witness how data transforms care into a personalized journey against aging and hear from the visionary Dr. Wei-Wu He.
In addition to an introduction into the science to reverse aging, you can connect with Wharton alums, indulge in stimulating conversations, and enjoy the curated refreshments.
About Human Longevity, Inc.
Human Longevity, Inc.(HLI), co-founded by the renowned Dr. Craig Venter, who sequenced the first human genome, is deeply committed to its mission of 'Improving Healthcare with Precision Medicine and AI-Driven Analytics'. This company has dedicated over a decade and invested over $500 million to develop an industry-leading, multi-modality platform, specifically tailored for precision medicine and longevity care, helping nearly 10,000 people in the process. HLI's integration of AI-driven analytics with precision medicine is not only transforming the landscape of healthcare but also paving the way for a future where medical care is more personalized, effective, and data-driven.
During the course of the event, we will hear the presentation from Dr. Wei-Wu He, WG’99, the Chairman and CEO of HPI, and network with Wharton alums. Drinks and light appetizers will be served.
Speaker: Dr. Wei-Wu He, WG’99
Dr. Wei-Wu He is currently the Chairman and CEO of Human Longevity Inc. Prior to HLI, Dr. He was the CEO of OriGene Technologies, Inc. (merged with VcanBio. China A share:600645). He also is the founder and General Partner of Emerging Technology Partners, LLC (ETP), a life sciences focused venture fund established since 2000. Dr. He has been involved in founding or funding over 100 biotech companies throughout his career, many of them have been acquired or listed on public market. Dr. He was the founder and served as Chairman of many biotechnology companies such as Genetron Health, Juventas Cell Therapy, etc. In the earlier part of his career, Dr. He was one of the first few scientists at Human Genome Sciences ($4 Billion acquisition by GSK), and prior to that, was a research fellow at Massachusetts General Hospital and Mayo Clinic. Dr. He is an author to more than 30 research publications and inventor of over 30 issued patents. Dr. He received his PhD in Molecular Biology from Baylor College of Medicine and received an MBA degree from the Wharton School.
Agenda
3:30-4:00 pm: Check in
4-4:30 pm: Intro and tour of the center
4:30-5:00 pm: Presentation & discussion
5:00-5:30pm Networking over snacks/drinks
Register Online
Date: Friday, February 2, 2024
Time: 3:30pm to 5:30pm
Location: 600 Gateway Blvd. Suite 101, South San Francisco, CA 94080
Zoom link to be provided if only attending the online portion
Cost: WCNC members free, Non-Members $20 (in person) $10 (zoom)
Please contact
Claire Gao for any questions related to the event.
